📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asthma Inhaler Device Companies

Asthma inhalers are medical devices used by individuals with asthma and other respiratory conditions to deliver medications directly to the airways, providing relief from symptoms and improving lung function. Several companies specialize in the development and manufacturing of various types of asthma inhaler devices.

Asthma Inhaler Device Key CompaniesDisclaimer: List of key companies in no particular orderLatest Asthma inhalers Companies Update

  • Sep 2023: Torrent Pharma is reportedly trying to raise the money required to acquire the Cipla promoter family. Torrent has approached several private equity (PE) groups regarding a minority investment in the business, including Advent Worldwide, Bain Capital, Warburg Pincus, and CVC Capital. With an equity investment of almost Rs 8,000 crore ($1 billion), this could be the nation's biggest acquisition in the pharmaceutical industry to date. Furthermore, the Ahmedabad-based Torrent is negotiating share-backed promoter financing worth roughly Rs 9,000–10,000 crore ($1.1 billion) with domestic shadow banks and mutual funds. Regarding operations, chronic and sub-chronic segments account for over 70% of revenue for both Torrent and Cipla. Cipla has historically concentrated on the respiratory, anti-infectives, and urology segments, whereas Torrent possesses strengths in the therapeutic areas of cardiac, diabetes, neuro/CNS, and gastro. According to industry experts, their combined portfolio may consist of 33 mega brands—each with a turnover above Rs 100 crore—and leading positions in 270 brands within their respective therapeutic areas.

  • Aug 2023: German pharmaceutical manufacturer Boehringer Ingelheim sold its Ondero and Ondero Met brands to multinational pharmaceutical giant Lupin Ltd. The business notified the stock exchanges that it had successfully acquired the brands following a deed of assignments it had signed with Boehringer Ingelheim International GmbH, Germany, last year. The purchase of trademark rights for the diabetic products Ondero and Ondero Met is also included in this. As part of a comarketing partnership with Boehringer Ingelheim India, the multinational pharmaceutical firm located in Mumbai has been selling both brands in the Indian market since 2015.

List of Asthma inhalers Key companies in the market

  • GlaxoSmithKline plc (UK)

  • Koninklijke Philips NV (Netherlands)

  • AstraZeneca (UK)

  • Cipla Inc. (India)

  • Boehringer Ingelheim International GmbH (Germany)

  • Beximco Pharmaceuticals Ltd (Bangladesh)

  • Merck & Co., Inc. (the US)

  • Teva Pharmaceutical Industries Ltd (Israel)

  • Chiesi Farmaceutici SpA (Italy)

  • and Medisol Lifescience Pvt. Ltd (India)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.